Issuance of Shares

RNS Number : 5618P

Epistem Holdings plc

08 June 2015

 



RNS Press Release

For release:  8 June 2015

 Issuance of Shares

Epistem Holdings Plc (LSE: EHP, "Epistem" or "the Company"), the personalised medicine and biotechnology company, announces that 491,228 new ordinary shares of £0.015 each (the "New Ordinary Shares") have been issued and allotted to the vendors of Visible Genomics Limited pursuant to the achievement of the earnout condition relating to the receipt by the Company of regulatory approval in India for its Genedrive® TB molecular diagnostic test. The terms relating to the acquisition of Visible Genomics Limited on 27 July 2010 are detailed in the 2014 Annual Report.

Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to be effective on 12 June 2015. The New Ordinary Shares, which represent 4.6% of the enlarged share capital, will rank pari passu with the Company's existing ordinary shares and will be subject to a 24 months lock up, subject to customary exemptions.

Following admission of the New Ordinary Shares, Epistem will have 10,564,446 ordinary shares of £0.015 in issue.

 For further details please see contact:

Epistem Holdings Plc

Matthew Walls: Chief Executive Officer                                                         ++44 (0)161 606 7258

John Rylands: Finance Director

Peel Hunt LLP

James Steel                                                                                                           ++44 (0)207 418 8900

Clare Terlouw

Walbrook PR

Mike Wort                                                                                                             ++44 (0)207 933 8780

Anna Dunphy

 

END

 

 

LISUGURCQUPAGAR